HealthSystemCE.org HealthSystemCE.org The e-learning Center for Health-System Pharmacy Society Members

About Us

Goals of the Foundation for Continuing Professional Development

The primary purpose of the Foundation for Continuing Professional Development and it's website HealthSystemCE.org is to engage in activities that provide continuing education programming for pharmacists and pharmacy technicians through their respective state societies of health-system pharmacists.

The Foundation's Board of Directors is comprised of executives representing the California Society of Health-System Pharmacists, Illinois Council of Health-System Pharmacists, New York State Council of Health-system Pharmacists and Texas Society of Health-System Pharmacists.

The mission of The Foundation is to deliver high quality, fair and balanced online educational programming for pharmacists and pharmacy technicians and other health care professionals covering a variety of clinical, management and professional practice topics.

The Specific Goals of the Foundation include:

For additional information about the Foundation for Continuing Professional Development, please contact:

Paul F. Davis, R.Ph.
Executive Director
Texas Society of Health-System Pharmacists

For information regarding a specific educational program, please contact your local state association.

HealthSystemCE.org Participating Chapters:

Grant Support Provided By

Abbott

Allergan

AMGEN

Bayer HealthCare

Baxter

Braun

Bristol-Myers Squibb

Merck

Ortho-McNeil Janssen Scientific Affairs, L.L.C.

Pricara

Member Login

Email Address

Password

 I Forgot My Password

Access to HealthSystemCE.org is provided only to authorized members of participating chapters.

Polling Question

Has your organization adopted use of core performance quality measures for:

Pneumonia, Acute Myocardial Infarction or Heart Failure
Other disease state
Have not adopted use of core performance quality measures
Adoption of core performance measures in process

View Results

News - FDA Drug Shortages

News - FDA Drug Approval Reports